JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 23, 2004; DOI: 10.1124/jpet.103.063008


0022-3565/04/3092-677-683$20.00
JPET 309:677-683, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.063008v1
309/2/677    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzales, E. B.
Right arrow Articles by Dillon, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzales, E. B.
Right arrow Articles by Dillon, G. H.

NEUROPHARMACOLOGY

Enantioselectivity of {alpha}-Benzyl-{alpha}-methyl-{gamma}-butyrolactone-Mediated Modulation of Anticonvulsant Activity and GABAA Receptor Function

Eric B. Gonzales, Cathy L. Bell-Horner, Maria Antonette M. de la Cruz, James A. Ferrendelli, Douglas F. Covey, and Glenn H. Dillon

Department of Pharmacology and Neuroscience, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas (E.B.G., C.L.B.H., G.H.D.); Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri (M.A.M.C., D.F.C.); and Department of Neurology, University of Texas-Houston Medical School, Houston, Texas (J.A.F.)

Alkyl-substituted butyrolactones have both inhibitory and stimulatory effects on GABAA receptors. Lactones with small alkyl substitutions at the {alpha}-position positively modulate the channel, whereas {beta}-substituted lactones tend to inhibit the GABAA receptor. These compounds mediate inhibition through the picrotoxin site of the receptor. A distinct binding site that mediates the stimulatory actions of lactones is presumed to exist, although no definitive evidence to support this claim exists. In the present study, we used in vivo and in vitro assays to evaluate the effects of the enantiomers of a novel lactone, {alpha}-benzyl-{alpha}-methyl-{gamma}-butyrolactone ({alpha}-BnMeGBL), on the GABAA receptor. R-(-)-{alpha}-BnMeGBL was 2-fold more potent than the S-(+)-{alpha}-BnMeGBL in blocking pentylenetetrazol-induced seizures in CF-1 mice. The (+)-enantiomer inhibited binding of t-butylbicyclophosporothionate with a higher affinity than the (-)-enantiomer (IC50 of 0.68 and 1.1 mM, respectively). Whole cell patch-clamp recordings from recombinant {alpha}1{beta}2{gamma}2 receptors stably expressed in HEK293 cells demonstrated that both compounds stimulated GABA-activated current. The maximal stimulation was approximately 2-fold greater with (+)-{alpha}-BnMeGBL than that seen with (-)-{alpha}-BnMeGBL. Both enantiomers of {alpha}-BnMeGBL directly gated the GABAA receptor at mM concentrations, in a nonstereoselective manner. Our data demonstrate the stimulatory actions of {alpha}-BnMeGBL on GABAA receptor function display enantioselectivity and provide strong evidence for the existence of a true "lactone site" on the receptor.


Received November 14, 2003; accepted January 20, 2004.

Address correspondence to: Dr. Glenn H. Dillon, Department of Pharmacology and Neuroscience, University of North Texas Health Science Center at Fort Worth, 3500 Camp Bowie Blvd., Fort Worth, TX 76107. E-mail: gdillon{at}hsc.unt.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.